Search Results
Sep 15, 2025, 06:00 ET Gyala Therapeutics unveils first-in-class CAR-T therapy targeting CD84 showing strong preclinical efficacy in hard-to-treat leukemias
Hospital Clinic Barcelona and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Gyala builds on more than a decade of CAR-T research led by Dr. Juan. The institutions have
More news about: Gyala Therapeutics
Sep 15, 2025, 06:00 ET Gyala Therapeutics unveils first-in-class CAR-T therapy targeting CD84 showing strong preclinical efficacy in hard-to-treat leukemias
Hospital Clinic Barcelona and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Gyala builds on more than a decade of CAR-T research led by Dr. Juan. The institutions have
More news about: Gyala Therapeutics
Sep 15, 2025, 06:00 ET Gyala Therapeutics stellt erste CAR-T-Therapie ihrer Klasse vor, die auf CD84 abzielt und eine starke präklinische Wirksamkeit bei schwer zu behandelnden Leukämien zeigt.
Hospital Clinic Barcelona und des August Pi i Sunyer Biomedical Research Institute (IDIBAPS) gegründet und baut auf mehr als einem Jahrzehnt CAR-T-Forschung unter der Leitung von Dr. Juan
More news about: Gyala Therapeutics
Sep 15, 2025, 06:00 ET Gyala Therapeutics dévoile la première thérapie CAR-T de sa catégorie ciblant CD84, qui montre une forte efficacité préclinique dans les leucémies difficiles à traiter
Institut de recherche biomédicale August Pi i Sunyer (IDIBAPS), Gyala s'appuie sur plus d'une décennie de recherche CAR-T menée par le Dr Juan. Les institutions ont traité plus de 500 patients
More news about: Gyala Therapeutics
Sep 15, 2025, 06:00 ET Gyala Therapeutics presenta la primera terapia CAR-T de su clase
Barcelona y del August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Gyala se basa en más de una década de investigación en terapias CAR-T, liderada por el Dr. Juan.
More news about: Gyala Therapeutics
Sep 12, 2025, 09:55 ET Copper Mountain Technologies Introduces Affordable New VTR0102 and VTR0302 VNAs for a Broad Range of RF Applications
or Linux operating system on a PC, laptop, tablet, or x86 board single-board computer, the VNA software will execute on ARM processors, so a Raspberry Pi can be used to operate these VNAs. By combining this performance and versatility with accessible pricing, the VTR0102 and VTR0302 empower engineers to
More news about: Copper Mountain Technologies
Sep 11, 2025, 08:00 ET Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer with Paxalisib Monotherapy
samples from Stage IV HER2-positive metastatic breast cancer (mBC) patients were profiled to evaluate the effect of paxalisib, Kazia's investigational PI3K–mTOR inhibitor, on metastatic burden. Paxalisib monotherapy demonstrated a statistically significant reduction in single circulating tumor cells and
More news about: Kazia Therapeutics Limited
Sep 11, 2025, 00:58 ET ROHM hat einen ultrakompakten CMOS-Operationsverstärker entwickelt: mit branchenweit führendem extrem niedrigen Betriebsstrom
https://cdn.kyodonewsprwire.jp/prwfile/release/M106254/202508284225/_prw_PI1fl_92DOFqxS.jpg ROHM hat seine Prozess-, Verpackungs- und proprietären Nano Energy (TM) (*2)-Schaltungstechnologien
More news about: ROHM Co., Ltd.
Sep 10, 2025, 16:54 ET XingImaging in partnership with SynuSight was awarded a grant from The Michael J. Fox Foundation to support development of the α-synuclein PET tracer 18F-FD4 for Parkinson's disease
early stage of synucleinopathies, enabling proactive therapeutic strategies. Roger Gunn, CSO at Xing Imaging, and PI says, "This represents a pivotal opportunity to advance one of the most promising alpha-synuclein PET tracers in humans, ensuring its full characterization
More news about: XingImaging, LLC
Sep 10, 2025, 16:40 ET XingImaging in partnership with SynuSight was awarded a grant from The Michael J. Fox Foundation to support development of the α-synuclein PET tracer 18F-FD4 for Parkinson's disease
early stage of synucleinopathies, enabling proactive therapeutic strategies. Roger Gunn, CSO at Xing Imaging, and PI says, "This represents a pivotal opportunity to advance one of the most promising alpha-synuclein PET tracers in humans, ensuring its full characterization
More news about: XingImaging, LLC
Sep 10, 2025, 14:30 ET DeFi Technologies stellt monatliches Unternehmens-Update bereit: Valour meldet 974 Millionen USD an AUM und Nettozuflüsse in Höhe von 91,7 Millionen USD im bisherigen Jahresverlauf, neben anderen wichtigen Entwicklungen
Börse Spotlight Stock Market ein, darunter Shiba Inu (SHIB), Pi (PI), Ondo (ONDO), Cronos (CRO), Mantle (MNT), VeChain (VET), Ethena (ENA) und Celestia (TIA). Valour hat auf SEK lautende ETPs für Shiba Inu (SHIB), Pi (PI), Ondo (ONDO), Cronos (CRO), Mantle (MNT), VeChain (VET), Ethena
More news about: DeFi Technologies Inc.
Sep 10, 2025, 08:05 ET RMX VAST™ Video Now Natively Supported in U.S. Government's TAK Platform
streams over MANET as well as real-time video streaming over constrained RF networks including HF using lightweight, low-power devices like Raspberry Pi. "With VAST™, TAK users can push more video through the same networks, doubling or even tripling capability," said John Dames. "We believe that
More news about: RMX Industries, Inc.
Sep 09, 2025, 15:00 ET Say Hello to Baseus PicoGo II Series: Faster, Smaller, and Safer
for convenient storage. This makes it ideal for traveling. Safer Charging: Certified by TUV Rheinland, the PicoGo AE11 uses high-quality PI chips and core components from leading international manufacturers to ensure safe and compatible charging. It also offers the prevention of overcharging.
More news about: Baseus Technology (HK) Co., Ltd